HomeNxStage Medical Inc.

NxStage Medical Inc.

NxStage Announces Significant Increase in Nx2me Connected Health® Platform Adoption

NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the number of home hemodialysis (HHD) patients using its Nx2me Connected Health® platform has increased 220% in the past year.1 Nx2me®...

US Release of MasterGuard® Plus Announced by Medisystems

4/13/18: President of the company reports early customer feedback has been very positive, validating many of the benefits.

NxStage System One Shows Improved Biochemical Outcomes and Broad Range Patient Suitability with More Frequent Hemodialysis According to Study

  Editors Note: Data presentations to be showcased at the 54th ERA-EDTA Congress NxStage Medical, Inc. (Nasdaq: NXTM), today announced new findings demonstrating positive biochemical outcomes related to more frequent hemodialysis with the NxStage® System One™. The data will be presented...